Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

147
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
147
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

382
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
382
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.2K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.2K
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

557
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
557
Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving01:29

Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving

100
Mechanistic models play a crucial role in algorithms for numerical problem-solving, particularly in nonlinear mixed effects modeling (NMEM). These models aim to minimize specific objective functions by evaluating various parameter estimates, leading to the development of systematic algorithms. In some cases, linearization techniques approximate the model using linear equations.
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
100
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

126
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
126

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

From Cell-Free Transcriptomes to Single-Cell Landscapes: Biomarker Discovery and Originating Cell Alteration Analysis via Graph Matrix Factorization.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Predicting miRNA-Drug Interactions Based on Multi-source Feature Fusion of Heterogeneous Network.

Interdisciplinary sciences, computational life sciences·2025
Same author

A Multi-modal Drug Target Affinity Prediction Based on Graph Features and Pre-trained Sequence Embeddings.

Interdisciplinary sciences, computational life sciences·2025
Same author

Circular RNA-Drug Association Prediction Based on Multi-Scale Convolutional Neural Networks and Adversarial Autoencoders.

International journal of molecular sciences·2025
Same author

An Integrated TCN-CrossMHA Model for Predicting circRNA-RBP Binding Sites.

Interdisciplinary sciences, computational life sciences·2024
Same author

Identification of circRNA-disease associations via multi-model fusion and ensemble learning.

Journal of cellular and molecular medicine·2024

Video Experimental Relacionado

Updated: Sep 9, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.8K

Optimización de la molécula de fármaco multiobjetivo basada en la distancia de aglomeración de Tanimoto y la

Yuxin Wang1, Cai Dai1, Xiujuan Lei1

  • 1School of Computer Science, Shaanxi Normal University, Xi'an 710119, China.

Pharmaceuticals (Basel, Switzerland)
|August 28, 2025
PubMed
Resumen

Este estudio introduce un algoritmo genético mejorado (MoGA-TA) para la optimización molecular de fármacos, mejorando la exploración y diversidad del espacio químico. MoGA-TA aumenta significativamente la eficiencia y las tasas de éxito en el descubrimiento de fármacos multiobjetivo.

Palabras clave:
Distancia de Tanimotodescubrimiento de fármacosalgoritmo evolutivoOptimización molecular

Más Videos Relacionados

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

521
Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology
06:24

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology

Published on: December 15, 2017

10.2K

Videos de Experimentos Relacionados

Last Updated: Sep 9, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.8K
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

521
Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology
06:24

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology

Published on: December 15, 2017

10.2K

Área de la Ciencia:

  • Química computacional
  • Descubrimiento de drogas
  • La bioinformática

Sus antecedentes:

  • Los métodos tradicionales de optimización molecular son intensivos en datos y costosos desde el punto de vista computacional.
  • Los algoritmos genéticos convencionales a menudo producen soluciones similares, limitando la exploración espacial química y arriesgando el óptimo local.
  • Los enfoques existentes se enfrentan a desafíos para mantener la diversidad molecular durante la optimización.

Objetivo del estudio:

  • Presentar un algoritmo genético mejorado, MoGA-TA, para la optimización molecular de fármacos multiobjetivo.
  • Mejorar la exploración del espacio químico y mantener la diversidad de la población en la optimización molecular.
  • Superar las limitaciones de los métodos tradicionales en la dependencia de datos y el costo computacional.

Principales métodos:

  • Desarrollado MoGA-TA utilizando el cálculo de la distancia de hacinamiento basado en la similitud de Tanimoto.
  • Implementó una estrategia de actualización de la población de probabilidad de aceptación dinámica para el equilibrio evolutivo.
  • Empleado un cruce desacoplado y la estrategia de mutación para el diseño molecular optimizado.

Principales resultados:

  • El MoGA-TA demostró un rendimiento superior en la optimización de moléculas de fármacos en comparación con los métodos existentes.
  • El algoritmo mejoró significativamente la eficiencia y la tasa de éxito de la optimización molecular.
  • Evaluación de la eficacia utilizando métricas que incluyen la tasa de éxito, el hipervolumen dominante y la similitud interna.

Conclusiones:

  • El MoGA-TA es un método eficaz y fiable para la optimización molecular multiobjetivo.
  • El enfoque propuesto mejora la exploración espacial de búsqueda y evita la convergencia prematura.
  • Este algoritmo ofrece una solución prometedora para desafíos complejos de descubrimiento de fármacos.